ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2023
Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs.
Kelly E Anderson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.